826 nett I, 274 F.Supp.2d at 104. Proximate cause will support this connection. See Furst Nationurde Bank v. Gelt Funding Corp., 27 F.3d 768, 769 (2d Cir.1994) (“Central to the notion of proximate cause is the idea that a person is not liable to all those who may have been injur...
Results for “Am. Arbitration Ass’n, Inc”
Search across the indexed text of every released document.
Names that match “Am. Arbitration Ass’n, Inc”
1,527 documents found
820 1533, 1537 (S.D.N.Y.1983) (holding corre- spondent banking relationships insufficient to create general personal jurisdiction). NCB offers its customers the opportunity to open accounts directly with United States-based securities broker-dealers, but NCB does not act as a br...
Third, the report highlights how powerful bipartisan constituencies have emerged in the past to tackle great issues for the betterment of our nation, including tax reform, civil liberties, healthcare, education and national defense. Just as presidents of both parties rose to the...
Or > A “Bw Plan fon on RO RUBICON . . ORGANICS Rubicon Organics Bellingham, Washington www.rubiconorganics.com Rubicon Organics is a licensed cannabis culti- vator specializing in the growing, processing, packaging and marketing of cannabis. The com- pany is developing greenho...
High-Level Thoughts on Income Statement/Balance Sheet KP CC —— USA Inc. | High Level Thoughts 25 How Would You Feel if... ...your Cash Flow was NEGATIVE for each of the past 9 years... ... your Net Worth* has been NEGATIVE for as long as you can remember... ... t would take...
Paul J. Set Theory and the Continuum Hypothesis. Dover Publications Inc.
USA Inc.’s financial liabilities -- whether they are actual
and/or was involved in Novamente LLC and Webmind Inc.
Inc. Therapeutics 7.7 19.4 - 19.4 2.51 2.51 581.9%
Inc. Therapeutics 2013 10.4 11.1 - 11.1 1.06 1.06 13.1%
Inc. Convergence 2011 88: 125 1.6 14.1 - 3.68 105.6%
Inc. Therapeutics 2011 20.6 27.0 44.9 71.9 3.07 3.50 57.7%
Inc. Therapeutics 2013 3.4 6.8 - 6.8 2.03 2.03 1583.0%
Inc. Diagnostics & Infrastructure 2008 10.7 - - - - - NM
Inc. Therapeutics 2012 10.5 34.1 - 34.1 3.24 3.24 323.6%